+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Myelodysplastic Syndrome With Excess Blasts2 - Pipeline Insight, 2025 - Product Thumbnail Image

Myelodysplastic Syndrome With Excess Blasts2 - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Non-Hodgkin Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Hodgkin Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Oropharyngeal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Oropharyngeal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Pancreatic Adenocarcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatic Adenocarcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pancreatic Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatic Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 260 Pages
  • Global
From
Pancreatic Ductal Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatic Ductal Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pancreatic Neuroendocrine Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatic Neuroendocrine Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Papilloma - Pipeline Insight, 2025 - Product Thumbnail Image

Papilloma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
PEComa - Pipeline Insight, 2025 - Product Thumbnail Image

PEComa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pediatric Neuroblastoma - Pipeline Insight, 2025 - Product Thumbnail Image

Pediatric Neuroblastoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Primary Myelofibrosis- Pipeline Insight, 2025 - Product Thumbnail Image

Primary Myelofibrosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Prostate Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Prostate Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Recurrent Glioblastoma - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Glioblastoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 200 Pages
  • Global
From
Tenosynovial Giant Cell Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Tenosynovial Giant Cell Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Testicular Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Testicular Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Transitional Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Transitional Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Triple Negative Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Triple Negative Breast Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Urothelial Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Urothelial Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 170 Pages
  • Global
From
Uveal Neoplasms - Pipeline Insight, 2025 - Product Thumbnail Image

Uveal Neoplasms - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cervical Intraepithelial Neoplasia- Pipeline Insight, 2025 - Product Thumbnail Image

Cervical Intraepithelial Neoplasia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more